Filing Flows › Freshpet (FRPT) › Guidance & outlook
Freshpet (FRPT) guidance and outlook
Freshpet (FRPT) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue +12% to +13% for FY2026; EBITDA $215M–$220M for FY2026; Capital expenditures $125M–$150M for FY2026; Gross margin 49% for FY2027. Freshpet's 10-Q filed Nov 4, 2026 makes 18 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | +12% to +13% | raised |
| EBITDA | FY2026 | $215M–$220M | raised |
| Capital expenditures | FY2026 | $125M–$150M | lowered |
| Gross margin | FY2027 | 49% | reaffirmed |
| EBITDA margin | FY2027 | 20%–22% | reaffirmed |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 4, 2026
- We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases.
- The Company recognizes share-based compensation based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period.
- Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.
- Additionally, Adjusted EBITDA excludes (i) non-cash share-based compensation expense, which is and will remain a key element of our overall long-term incentive compensation package, and (ii) certain costs essential to our sales growth and strategy.
- We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting.
- At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets.
- Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores.
- Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel.
- We expect to rely on our current and future cash flow from operations to fund our growth going forward.
- Our ability to obtain additional funding will be subject to various factors, including general economic and market conditions, our operating performance, the market’s perception of our growth potential, lender sentiment and our ability to incur additional debt in compliance with other contractual restrictions.
- We expect capital expenditures to total between approximately $125 to $150 million in fiscal year 2026.
- If our business does not achieve the levels of profitability or generate the amount of cash that we anticipate or if we expand faster than anticipated, we may need to seek additional debt or equity financing to operate and expand our business.
Freshpet's latest quarter
Freshpet, Q3 2026: revenue $318M (+10% year over year), operating margin 11.1%, net earnings $29.7M, operating cash flow $60.8M. The chart follows the revenue to costs, profit and cash.
Questions
Did Freshpet raise or lower its guidance?
Freshpet (FRPT) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue +12% to +13% for FY2026; EBITDA $215M–$220M for FY2026; Capital expenditures $125M–$150M for FY2026; Gross margin 49% for FY2027.
What does Freshpet expect?
We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases. The Company recognizes share-based compensation based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.